<DOC>
	<DOCNO>NCT01442025</DOCNO>
	<brief_summary>To investigate whether sustain trough level IFX achieve use IFX ( Infliximab ) trough level measurement adjustment dose base upon level mean two different standardize algorithms comparison 'standard care ' IFX treatment effect clinical endoscopic outcome .</brief_summary>
	<brief_title>Study Investigating Tailored Treatment With Infliximab Active Crohn 's Disease</brief_title>
	<detailed_description />
	<mesh_term>Crohn Disease</mesh_term>
	<mesh_term>Infliximab</mesh_term>
	<criteria>Age &gt; 18 year Active CD ( CDAI &gt; 220 ) sign active inflammation evidence elevated serum hsCRP level ( &gt; 5 mg/L ) and/or elevate fecal calprotectin level ( &gt; 250 µg/g ) endoscopically visible ulcer . Patients must naïve biologics indication start antiTNF therapy accordance national reimbursement criterion . Patients must naïve thiopurines fail therapy thiopurines ( case AZA continue ) . Ongoing steroid allow stable dose least 2 week maximum prednisone 40 mg/d budesonide 9 mg/day . Patients consent receive Infliximab 5 mg/kg week 0 , 2 6 every 8 week conjunction azathioprine ( 2,5 mg/kg/day ) . Patients develop AZA intolerance trial continue trial without AZA ( ie IFX monotherapy ) . Absence endoscopically visible ulcer Prior exposure infliximab ( biologics allow ) Ongoing steroid therapy dose &gt; 40 mg/d prednisolone equivalent Previous intolerance azathioprine lead drug discontinuation Ongoing infection Positive tuberculosis screen per local guideline Serious disease include cancer 5 year prior inclusion exclude nonmelanoma skin cancer Indication immediate surgery Pregnant breastfeed woman . Positive fecal culture Salmonella , Shigella , Yersinia Campylobacter and/or presence Clostridium difficile B toxin stool Active tuberculosis Untreated latent tuberculosis ( see national recommendation . Appendix 2 ) . Noncompliant subject . Participation another therapeutic study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>Crohn 's Disease</keyword>
	<keyword>IFX trough level</keyword>
</DOC>